Association of Graves’ disease with an allele of the interleukin-1 receptor antagonist gene

Journal of Clinical Endocrinology and Metabolism

Volumn 80, Issue 1, 1995, Pages 111-115

  Blakemore, A I F ^a   Watson, P F ^a   Weetman, A P ^a   Duff, G W ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHYROID AGENT; CYTOKINE; DNA; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; THYROID ANTIBODY;

ADULT; ALLELE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; GRAVES DISEASE; HASHIMOTO DISEASE; HUMAN; IMMUNOPATHOGENESIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RECEPTOR BLOCKING;

ALLELES; ANTITHYROID AGENTS; COHORT STUDIES; EYE DISEASES; FEMALE; GENES; GENOTYPE; GRAVES' DISEASE; HUMAN; MALE; RECEPTORS, INTERLEUKIN-1; SUPPORT, NON-U.S. GOV'T; THYROIDITIS, AUTOIMMUNE;

EID: 0028873472     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jcem.80.1.7530255     Document Type: Article

References (40)

1. Volpe R, Edmonds M, Lamkl L, Clarke PV, Row VV. 1972 The pathogenesis of Graves’ disease: a disorder of delayed hypersensitivity? Mayo Clin Proc. 47: 824-833.
2. Hall R, Owen SF, Smith GS. 1964 Evidence for a genetic predisposition to formation of thyroid autoantibodies. Lancet. 2: 187-188.
3. Weetman AP. 1991 Autoimmune endocrine disease. Cambridge: Cambridge University Press.
4. Sridama V, Hara Y, Fauchet R, DeGroot LJ. 1987 HLA immuno-genetic heterogeneity in black American patients with Graves’ disease. Arch Intern Med. 147: 229-231.
5. Inoue D, Sato K, Enomoto T, 1992 Correlation of HLA types and clinical findings in Japanese patients with hyperthyroid Graves’ disease: evidence indicating the existence of four subpopulations. Clin Endocrinol (Oxf). 36: 75-82.
6. Manklabruks A, Cox N, DeGroot LJ. 1991 Genetic factors in autoimmune thyroid disease analyzed by restriction fragment length polymorphisms of candidate genes. J Clin Endocrinol Metab. 73: 236-244.
7. Jenkins M, Penny MA, Fletcher JA, 1992 HLA class II gene polymorphism contributes little to Hashimoto’s thyroiditis. Clin Endocrinol (Oxf). 37: 141-145.
8. Yanagawa T, Manglabruks A, Chang Y-B, 1993 Human his-tocompatability leukocyte antigen-DQA1 *0501 allele associated with genetic susceptibility to Graves’ disease in a Caucasian population. J Clin Endocrinol Metab. 76: 1569-1574.
9. Ratanachaiyavong S, Lloyd L, Darke C, McGregor AM. 1993 MHC extended haplotypes in families of patients with Graves’ disease. Hum Immunol. 36: 99-111.
10. Ratanachaiyavong S, Demaine AG, Campbell RD, McGregor AM. 1991 Heat shock protein 70 (HSP70) and complement C4 genotypes in patients with hyperthyroid Graves’ disease. Clin Exp Immunol. 84: 48-52.
11. Badenhoop K, Schwartz G, Schleusener H, 1992 Tumor necrosis factor-? gene polymorphisms in Graves’ disease. J Clin Endocrinol Metab. 74: 287-291.
12. Stenszky V, Kozma L, Balzacs C, Rochlitz S, Bear JC, Farid NR. 1985 The genetics of Graves’ disease: HLA and disease susceptibility. J Clin Endocrinol Metab. 61: 735-739.
13. Roman S, Greenberg D, Rubinstein P, Wallenstein S, Davies TF. 1992 Genetics of autoimmune thyroid disease: lack of evidence for linkage to HLA within families. J Clin Endocrinol Metab. 74: 496-503.
14. Tamai H, Uno H, Hirota Y, 1985 Immunogenetics of Hashimoto’s and Graves’ diseases. J Clin Endocrinol Metab. 60: 62-66.
15. Weetman AP, So AK, Warner CA, Foroni L, Fells P, Shine B. 1988 Immunogenetics of Graves’ ophthalmopathy. Clin Endocrinol (Oxf). 28: 619-628.
16. Weetman AP, Brazier DM. 1988 Immunoglobulin allotypes in Graves’ disease. Tissue Antigens. 32: 71-72.
17. Duff GW. 1989 Protein regulatory factors in non-malignant diseases. Lancet. 8652: 1432-1435.
18. Asakawa H, Hanafusa T, Oda Y, 1991 Human recombinant interleukin-1 inhibits TSH-stimulated morphological changes in thyroid follicles cultured as semi-organs. Acta Endocrinol (Copenh). 125: 80-85.
19. Grubeck-Loebenstein B, Buchan G, Chantry D, 1989 Analysis of intrathyroidal cytokine production in thyroid autoimmune disease: thyroid follicular cells produce interleukin-la and interleukin-6. Clin Exp Immunol. 77: 324-330.
20. Kawabe Y, Eguchi K, Shimonura C, 1989 Interleukin-1 production and action in thyroid tissue. J Clin Endocrinol Metab. 68: 1174-1183.
21. Heufelder AE, Bahn RS. 1992 Graves’ immunoglobulins and cytokines stimulate the expression of intracellular adhesion molecule-1 (ICAM-1) in cultured Graves’ orbital fibroblasts. Eur J Clin Invest. 22: 529-537.
22. Heufelder AE, Bahn RS. 1993 Detection and localization of cytokine immunoreactivity in retro-ocular connective tissue in Graves’ ophthalmopathy. Eur J Clin Invest. 23: 10-17.
23. Metcalfe RA, Weetman AP. 1994 Stimulation of extraocular muscle fibroblasts by cytokines and hypoxia: possible role in thyroid-associated ophthalmopathy. Clin Endocrinol (Oxf). 40: 67-72.
24. Arend WP. 1991 Interleukin-1 receptor antagonist. A new member of the interleukin-1 family. J Clin Invest. 88: 1445.
25. Dinarello CA, Thomson G. 1991 Blocking IL-1: interleukin 1 receptor antagonist in vivo and in vitro. Immunol Today. 12: 404-410.
26. Haskill JS, Martin G, Van Le L, 1991 cDNA cloning of an intracellular form of the human interleukin 1 receptor antagonist associated with epithelium, Proc Natl Acad Sci USA. 88: 3681-3685.
27. Tarlow JK, Blakemore AIF, Lennard A, 1993 Polymorphism in human IL-1 receptor antagonist gene intron 2 is caused by variable numbers of an 86 bp tandem repeat. Hum Ccnet. 91: 403 404.
28. Blakemore AIF, Tarlow JT, Cork MJ, Gordon C, Emery P, Duff GW. 1994 Interleukin-1 receptor antagonist gene polymorphism as a severity factor in systemic lupus erythematosus. Arthritis Rheum. 37: 1380-1385.
29. Tarlow JK, Clay FE, Cork MJ, 1994 Alopecia areata is associated with a polymorphism in the interleukin-1 receptor antagonist gene. J Invest Dermatol. 103: 387-390.
30. Clay FE, Tatlow JK, Blakemore AIF, 1994 Interleukin-1 receptor antagonist gene polymorphism association with lichen scle-rosus. Hum Genet. 94: 407-410.
31. Weehnan AP, Rennie DP, Hassman R, Hall R, McGregor AM. 1984 Enzyme-linked immunoassay of monoclonal and serum microsomal autoantibodies. Clin Chim Acta. 138: 237-244.
32. Weetman AP, Ralanachaiyavong S, Middleton GW, 1986 Prediction of outcome in Graves’ disease after carbimazole therapy. Q J Med. 56: 409-419.
33. Heufelder AE, Wenzel BE, Gorman CA, Bahn RS. 1991 Detection, cellular localization and modulation of heat shock proteins in cultured fibroblasts from patients with extrathyroidal manifestations of Graves’ disease. J Clin Endocrinol Metab. 73: 739-745.
34. Weetman AP, Cohen S, Makgoba MW, Borysiewicz LK. 1989 Expression of an intracellular adhesion molecule, ICAM-1, by human thyroid cells. J Endocrinol (Oxf). 122: 185-191.
35. Tandon N, Makgoba MW, Gahmberg CG, Weetman AP. 1992 The expression and role in T-cell adhesion of LFA-3 and ICAM-1 on human thyroid cells. Clin Immunol Immunopathol. 1: 30-35.
36. Weetman AP, Bright-Thomas R, Freeman M. 1990 Regulation of interleukin-6 release by human thyrocytes. J Endocrinol. 127: 357-361.
37. Weetman AP, Bennett GL, Wong WLT. 1992 Thyroid follicular cells produce interleukin-8. J Clin Endocrinol Metab. 75: 328-330.
38. Tandon N, Morgan BP, Weetman AP. 1992 Expression and function of membrane attack complex inhibitory proteins on thyroid follicular cells. Immunology. 75: 372-377.
39. Tandon N, Yan SL, Morgan BP, Weetman AP. 1994 Expression and fuction of multiple regulators of complement activation of autoimmune thyroid disease. Immunology. 81: 643-647.
40. Heufelder AE, Goellner JR, Wenzel BE, Bahn RS. 1992 Immuno-histochemical detection and localization of a 72-kilodalton heat shock protein in thyroid disease. J Clin Endocrinol Metab. 74: 724-731.